eClinical Solutions Market By Deployment Type (Electronic Data Capture, Electronic Clinical Outcome Assessment, Clinical Data Management System, and Clinical Trial Management System, Clinical Analytics Platform, Randomization and Trial Supply Management, Electronic Trial Master File and Others), By Mode of Delivery(Web/Cloud based System and On Premise System), By End user (Pharmaceutical And Biotech Companies, Hospitals, Clinical Research Organizations, Medical Device Manufacturers and Others) and By Region - Trends, Analysis and Forecast till 2034

The incidence of chronic diseases is rising.

An important factor fueling the eClinical solution market's expansion is the rising incidence of chronic illnesses like cancer, COPD, diabetes, and cardiovascular disease. The demand for eClinical solutions is further supported by the gradual expansion of research and development efforts by significant biotech and pharmaceutical companies searching for disease-modifying treatments. According to a 2017 report by the International Federation of Pharmaceutical Manufacturers and Association, the pharmaceutical and biotech industries jointly spend approximately US$ 149.8 billion in the drug development process. Furthermore, there are currently about 7,000 compounds in the preclinical research stage; in 2015, about 56 new medications were introduced, and between 2011 and 2015, about 225 novel chemical and biological entities were introduced.